Clinical Feasibility of Exercise-Based A-V Interval Optimization for Cardiac Resynchronization: A Pilot Study

Background One‐third of eligible patients fail to respond to cardiac resynchronization therapy (CRT). Current methods to “optimize” the atrio‐ventricular (A‐V) interval are performed at rest, which may limit its efficacy during daily activities. We hypothesized that low‐intensity cardiopulmonary exe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pacing and clinical electrophysiology 2014-11, Vol.37 (11), p.1499-1509
Hauptverfasser: CHOUDHURI, INDRAJIT, MACCARTER, DEAN, SHAW, RACHAEL, ANDERSON, STEVE, ST. CYR, JOHN, NIAZI, IMRAN
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background One‐third of eligible patients fail to respond to cardiac resynchronization therapy (CRT). Current methods to “optimize” the atrio‐ventricular (A‐V) interval are performed at rest, which may limit its efficacy during daily activities. We hypothesized that low‐intensity cardiopulmonary exercise testing (CPX) could identify the most favorable physiologic combination of specific gas exchange parameters reflecting pulmonary blood flow or cardiac output, stroke volume, and left atrial pressure to guide determination of the optimal A‐V interval. Methods We assessed relative feasibility of determining the optimal A‐V interval by three methods in 17 patients who underwent optimization of CRT: (1) resting echocardiographic optimization (the Ritter method), (2) resting electrical optimization (intrinsic A‐V interval and QRS duration), and (3) during low‐intensity, steady‐state CPX. Five sequential, incremental A‐V intervals were programmed in each method. Assessment of cardiopulmonary stability and potential influence on the CPX‐based method were assessed. Results CPX and determination of a physiological optimal A‐V interval was successfully completed in 94.1% of patients, slightly higher than the resting echo‐based approach (88.2%). There was a wide variation in the optimal A‐V delay determined by each method. There was no observed cardiopulmonary instability or impact of the implant procedure that affected determination of the CPX‐based optimized A‐V interval. Conclusions Determining optimized A‐V intervals by CPX is feasible. Proposed mechanisms explaining this finding and long‐term impact require further study.
ISSN:0147-8389
1540-8159
DOI:10.1111/pace.12449